Rank | Gene Set | Z-score |
---|---|---|
1 | DNA deamination (GO:0045006) | 5.17668810 |
2 | ribosomal small subunit assembly (GO:0000028) | 4.51798064 |
3 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.11678032 |
4 | viral transcription (GO:0019083) | 4.05185407 |
5 | translational termination (GO:0006415) | 3.92474964 |
6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.90468679 |
7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.90468679 |
8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.79396276 |
9 | cytidine deamination (GO:0009972) | 3.72905338 |
10 | cytidine metabolic process (GO:0046087) | 3.72905338 |
11 | cytidine catabolic process (GO:0006216) | 3.72905338 |
12 | maturation of SSU-rRNA (GO:0030490) | 3.69964379 |
13 | leukocyte aggregation (GO:0070486) | 3.69680305 |
14 | negative regulation of cell killing (GO:0031342) | 3.61156676 |
15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.61156676 |
16 | sequestering of actin monomers (GO:0042989) | 3.59893524 |
17 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.58864063 |
18 | translational elongation (GO:0006414) | 3.58314523 |
19 | ribosomal small subunit biogenesis (GO:0042274) | 3.54513914 |
20 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.49503417 |
21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.49313084 |
22 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.49123668 |
23 | formation of translation preinitiation complex (GO:0001731) | 3.42521825 |
24 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.41139288 |
25 | DNA strand elongation (GO:0022616) | 3.40833456 |
26 | positive regulation of B cell differentiation (GO:0045579) | 3.35969318 |
27 | translational initiation (GO:0006413) | 3.31126070 |
28 | protein targeting to ER (GO:0045047) | 3.30395707 |
29 | cotranslational protein targeting to membrane (GO:0006613) | 3.29754290 |
30 | protein maturation by protein folding (GO:0022417) | 3.29449863 |
31 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.26724263 |
32 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.26288245 |
33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.22472730 |
34 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.20724284 |
35 | DNA unwinding involved in DNA replication (GO:0006268) | 3.18637961 |
36 | viral life cycle (GO:0019058) | 3.18485197 |
37 | regulation of protein heterodimerization activity (GO:0043497) | 3.15295288 |
38 | positive T cell selection (GO:0043368) | 3.14619988 |
39 | protein localization to endoplasmic reticulum (GO:0070972) | 3.13139168 |
40 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.11458907 |
41 | negative thymic T cell selection (GO:0045060) | 3.11006892 |
42 | cellular protein complex disassembly (GO:0043624) | 3.06187279 |
43 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.05616231 |
44 | telomere maintenance via recombination (GO:0000722) | 3.05463548 |
45 | negative T cell selection (GO:0043383) | 3.02037764 |
46 | positive regulation of lamellipodium assembly (GO:0010592) | 3.01761150 |
47 | DNA replication initiation (GO:0006270) | 3.00245872 |
48 | positive thymic T cell selection (GO:0045059) | 3.00062127 |
49 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.98916480 |
50 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.98359753 |
51 | proteasome assembly (GO:0043248) | 2.98234554 |
52 | negative regulation of B cell apoptotic process (GO:0002903) | 2.96963587 |
53 | regulation of defense response to virus by virus (GO:0050690) | 2.93076821 |
54 | T cell selection (GO:0045058) | 2.90600591 |
55 | actin nucleation (GO:0045010) | 2.90595662 |
56 | pinocytosis (GO:0006907) | 2.90236000 |
57 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.89443385 |
58 | negative regulation of phagocytosis (GO:0050765) | 2.89331779 |
59 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.88734147 |
60 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.86149209 |
61 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.86149209 |
62 | ribosomal large subunit biogenesis (GO:0042273) | 2.85701018 |
63 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.84298379 |
64 | respiratory burst (GO:0045730) | 2.80015252 |
65 | regulation of gamma-delta T cell activation (GO:0046643) | 2.78699851 |
66 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.77609971 |
67 | regulation of T cell tolerance induction (GO:0002664) | 2.77389718 |
68 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.77201359 |
69 | type I interferon signaling pathway (GO:0060337) | 2.77126959 |
70 | cellular response to type I interferon (GO:0071357) | 2.77126959 |
71 | mature B cell differentiation involved in immune response (GO:0002313) | 2.76290205 |
72 | mitotic recombination (GO:0006312) | 2.75809191 |
73 | protein complex disassembly (GO:0043241) | 2.75445932 |
74 | T cell costimulation (GO:0031295) | 2.74879056 |
75 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.73932648 |
76 | neutrophil activation involved in immune response (GO:0002283) | 2.71938314 |
77 | response to type I interferon (GO:0034340) | 2.71790676 |
78 | lymphocyte costimulation (GO:0031294) | 2.70600177 |
79 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.69544692 |
80 | immunoglobulin mediated immune response (GO:0016064) | 2.66480315 |
81 | B cell mediated immunity (GO:0019724) | 2.66069785 |
82 | telomere maintenance via telomere lengthening (GO:0010833) | 2.65935356 |
83 | negative regulation of T cell apoptotic process (GO:0070233) | 2.65852778 |
84 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.65355218 |
85 | thymic T cell selection (GO:0045061) | 2.64740555 |
86 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.64704548 |
87 | detection of bacterium (GO:0016045) | 2.64160000 |
88 | NIK/NF-kappaB signaling (GO:0038061) | 2.63743153 |
89 | GDP-mannose metabolic process (GO:0019673) | 2.63409162 |
90 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.62322579 |
91 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.61897991 |
92 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.61694854 |
93 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.61694854 |
94 | modulation by symbiont of host immune response (GO:0052553) | 2.61694854 |
95 | positive regulation by symbiont of host defense response (GO:0052509) | 2.61694854 |
96 | modulation by symbiont of host defense response (GO:0052031) | 2.61694854 |
97 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.61694854 |
98 | B cell receptor signaling pathway (GO:0050853) | 2.60684023 |
99 | T cell apoptotic process (GO:0070231) | 2.60281665 |
100 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.59949758 |
101 | response to peptidoglycan (GO:0032494) | 2.59453509 |
102 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.58238536 |
103 | negative regulation of interleukin-12 production (GO:0032695) | 2.58158814 |
104 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.57214535 |
105 | macromolecular complex disassembly (GO:0032984) | 2.56956768 |
106 | negative regulation of ligase activity (GO:0051352) | 2.56660677 |
107 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.56660677 |
108 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.56242966 |
109 | negative regulation of viral genome replication (GO:0045071) | 2.56007894 |
110 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.55816094 |
111 | establishment of viral latency (GO:0019043) | 2.54893076 |
112 | translation (GO:0006412) | 2.54834461 |
113 | response to interleukin-15 (GO:0070672) | 2.54354889 |
114 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.53814700 |
115 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.53177349 |
116 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.52191138 |
117 | mitotic nuclear envelope disassembly (GO:0007077) | 2.52030050 |
118 | positive regulation of lamellipodium organization (GO:1902745) | 2.52005809 |
119 | ribosome biogenesis (GO:0042254) | 2.51905607 |
120 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.51882409 |
121 | cellular response to interleukin-15 (GO:0071350) | 2.51242361 |
122 | T cell receptor signaling pathway (GO:0050852) | 2.51165361 |
123 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.50771481 |
124 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.50178133 |
125 | rRNA processing (GO:0006364) | 2.49992253 |
126 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.49553934 |
127 | protein localization to kinetochore (GO:0034501) | 2.49408625 |
128 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.48039563 |
129 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.48039563 |
130 | establishment of integrated proviral latency (GO:0075713) | 2.47779522 |
131 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.47073356 |
132 | Peyers patch development (GO:0048541) | 2.47073356 |
133 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.46810406 |
134 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.46487645 |
135 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.46425134 |
136 | detection of other organism (GO:0098543) | 2.46310136 |
137 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.46157761 |
138 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.46071178 |
139 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.45789102 |
140 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.45789102 |
141 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.45789102 |
142 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.45319275 |
143 | T cell migration (GO:0072678) | 2.43708107 |
144 | mRNA catabolic process (GO:0006402) | 2.43540323 |
145 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.43516450 |
146 | COPI coating of Golgi vesicle (GO:0048205) | 2.42999356 |
147 | Golgi transport vesicle coating (GO:0048200) | 2.42999356 |
148 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.42897391 |
149 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.42378181 |
150 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.41058196 |
151 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.41058196 |
152 | rRNA metabolic process (GO:0016072) | 2.40903398 |
153 | RNA catabolic process (GO:0006401) | 2.39724387 |
154 | ribosome assembly (GO:0042255) | 2.39421100 |
155 | response to interferon-beta (GO:0035456) | 2.39377070 |
156 | positive regulation of macrophage differentiation (GO:0045651) | 2.39220040 |
157 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.39106570 |
158 | negative regulation of RNA splicing (GO:0033119) | 2.39074556 |
159 | interferon-gamma production (GO:0032609) | 2.37674533 |
160 | regulation of B cell differentiation (GO:0045577) | 2.36975268 |
161 | nucleobase biosynthetic process (GO:0046112) | 2.36632138 |
162 | positive regulation of isotype switching (GO:0045830) | 2.36574077 |
163 | regulation of translational termination (GO:0006449) | 2.36403223 |
164 | pseudouridine synthesis (GO:0001522) | 2.36383912 |
165 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.35580135 |
166 | DNA replication checkpoint (GO:0000076) | 2.35196309 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.57198757 |
2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.86605149 |
3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.18049775 |
4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.60268775 |
5 | * MYC_22102868_ChIP-Seq_BL_Human | 2.54429701 |
6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.36094988 |
7 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.35216438 |
8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.34465326 |
9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.24454457 |
10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.22051247 |
11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.20339336 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.17807787 |
13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.17217190 |
14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.17018440 |
15 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.15049859 |
16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.12645109 |
17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.12599616 |
18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.09672042 |
19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.08579803 |
20 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05256031 |
21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.05093801 |
22 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.04501737 |
23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.95976973 |
24 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.93846555 |
25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.90379966 |
26 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90329086 |
27 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.88187251 |
28 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.86393094 |
29 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.80931538 |
30 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.78684009 |
31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.74550750 |
32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74295262 |
33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.72727439 |
34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.71784633 |
35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.70841036 |
36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68151417 |
37 | * MAF_26560356_Chip-Seq_TH1_Human | 1.67346536 |
38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.66998622 |
39 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65218951 |
40 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.62937512 |
41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.62616053 |
42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.62124353 |
43 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.61971181 |
44 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.61220544 |
45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60799869 |
46 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.60646644 |
47 | MYB_26560356_Chip-Seq_TH2_Human | 1.57823361 |
48 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.56841416 |
49 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.55188971 |
50 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.54389670 |
51 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.53554599 |
52 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.52358219 |
53 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.47120567 |
54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.45033310 |
55 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42403057 |
56 | * MYB_26560356_Chip-Seq_TH1_Human | 1.41852795 |
57 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40757746 |
58 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.39872928 |
59 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39682561 |
60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38736208 |
61 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.38478909 |
62 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36389043 |
63 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.34026270 |
64 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32166781 |
65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.32011747 |
66 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.31924560 |
67 | MAF_26560356_Chip-Seq_TH2_Human | 1.31055542 |
68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.29539059 |
69 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.28992303 |
70 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.28203521 |
71 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.27230727 |
72 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27131878 |
73 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26592032 |
74 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.26277283 |
75 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.26244172 |
76 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.26189336 |
77 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.25466730 |
78 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.24649954 |
79 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.24529459 |
80 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.24119850 |
81 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23412940 |
82 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.23288215 |
83 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.23156514 |
84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18926268 |
85 | P68_20966046_ChIP-Seq_HELA_Human | 1.17355313 |
86 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17210755 |
87 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17074594 |
88 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16665794 |
89 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.16467485 |
90 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16079198 |
91 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.15230079 |
92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15182880 |
93 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.15064199 |
94 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.14992231 |
95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14542343 |
96 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14531852 |
97 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.14195514 |
98 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.13747175 |
99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13673240 |
100 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13603920 |
101 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.13263426 |
102 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.12075139 |
103 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.11950490 |
104 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11324983 |
105 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.10340991 |
106 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09689134 |
107 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.09510193 |
108 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.08503820 |
109 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08472276 |
110 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.08364581 |
111 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.08332157 |
112 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.08246666 |
113 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06933003 |
114 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06500682 |
115 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06088000 |
116 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05660185 |
117 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.05378174 |
118 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04832026 |
119 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04711639 |
120 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.04546865 |
121 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04284151 |
122 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03938313 |
123 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.03818039 |
124 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.03747339 |
125 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03727289 |
126 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.03071368 |
127 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.99991719 |
128 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99784205 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 3.12474530 |
2 | MP0003763_abnormal_thymus_physiology | 3.11540475 |
3 | MP0001835_abnormal_antigen_presentation | 2.90025518 |
4 | MP0005671_abnormal_response_to | 2.83576041 |
5 | MP0000685_abnormal_immune_system | 2.81724611 |
6 | MP0002396_abnormal_hematopoietic_system | 2.74174633 |
7 | MP0004957_abnormal_blastocyst_morpholog | 2.49307710 |
8 | MP0003436_decreased_susceptibility_to | 2.48339531 |
9 | MP0009333_abnormal_splenocyte_physiolog | 2.41561569 |
10 | MP0009785_altered_susceptibility_to | 2.37548830 |
11 | MP0001800_abnormal_humoral_immune | 2.30221127 |
12 | MP0002398_abnormal_bone_marrow | 2.25602634 |
13 | MP0003111_abnormal_nucleus_morphology | 2.18842768 |
14 | MP0003077_abnormal_cell_cycle | 2.18127706 |
15 | MP0005000_abnormal_immune_tolerance | 2.16383741 |
16 | MP0002420_abnormal_adaptive_immunity | 2.11899165 |
17 | MP0002452_abnormal_antigen_presenting | 2.10856037 |
18 | MP0001819_abnormal_immune_cell | 2.09857100 |
19 | MP0005025_abnormal_response_to | 2.08672240 |
20 | MP0002723_abnormal_immune_serum | 2.03629430 |
21 | MP0010352_gastrointestinal_tract_polyps | 2.03590600 |
22 | MP0010094_abnormal_chromosome_stability | 2.03250089 |
23 | MP0002405_respiratory_system_inflammati | 2.00771137 |
24 | MP0002877_abnormal_melanocyte_morpholog | 2.00057799 |
25 | MP0002722_abnormal_immune_system | 1.97834945 |
26 | MP0002166_altered_tumor_susceptibility | 1.95658826 |
27 | MP0001790_abnormal_immune_system | 1.94502096 |
28 | MP0005387_immune_system_phenotype | 1.94502096 |
29 | MP0005451_abnormal_body_composition | 1.92899735 |
30 | MP0000689_abnormal_spleen_morphology | 1.92376003 |
31 | MP0000490_abnormal_crypts_of | 1.91565704 |
32 | MP0000716_abnormal_immune_system | 1.90682236 |
33 | MP0004808_abnormal_hematopoietic_stem | 1.87826732 |
34 | MP0001853_heart_inflammation | 1.83375674 |
35 | MP0000703_abnormal_thymus_morphology | 1.82091595 |
36 | MP0001545_abnormal_hematopoietic_system | 1.78993550 |
37 | MP0005397_hematopoietic_system_phenotyp | 1.78993550 |
38 | MP0002429_abnormal_blood_cell | 1.76039399 |
39 | MP0002419_abnormal_innate_immunity | 1.69943645 |
40 | MP0008007_abnormal_cellular_replicative | 1.69516180 |
41 | MP0010155_abnormal_intestine_physiology | 1.68795727 |
42 | MP0003724_increased_susceptibility_to | 1.67579921 |
43 | MP0000858_altered_metastatic_potential | 1.67473845 |
44 | MP0001873_stomach_inflammation | 1.65275295 |
45 | MP0002006_tumorigenesis | 1.63545231 |
46 | MP0002148_abnormal_hypersensitivity_rea | 1.62697844 |
47 | MP0006082_CNS_inflammation | 1.59297873 |
48 | MP0005464_abnormal_platelet_physiology | 1.58129929 |
49 | MP0008057_abnormal_DNA_replication | 1.51614029 |
50 | MP0003303_peritoneal_inflammation | 1.49553948 |
51 | MP0006054_spinal_hemorrhage | 1.48759519 |
52 | MP0004947_skin_inflammation | 1.48137934 |
53 | MP0002933_joint_inflammation | 1.46986646 |
54 | MP0002019_abnormal_tumor_incidence | 1.43857222 |
55 | MP0005023_abnormal_wound_healing | 1.37951051 |
56 | MP0001845_abnormal_inflammatory_respons | 1.36853933 |
57 | MP0003300_gastrointestinal_ulcer | 1.36002354 |
58 | MP0008260_abnormal_autophagy | 1.34042513 |
59 | MP0009278_abnormal_bone_marrow | 1.31955332 |
60 | MP0003866_abnormal_defecation | 1.31789032 |
61 | MP0008058_abnormal_DNA_repair | 1.31485366 |
62 | MP0000465_gastrointestinal_hemorrhage | 1.27688069 |
63 | MP0001730_embryonic_growth_arrest | 1.24443501 |
64 | MP0003075_altered_response_to | 1.22200552 |
65 | MP0000350_abnormal_cell_proliferation | 1.20362319 |
66 | MP0002132_abnormal_respiratory_system | 1.17198803 |
67 | MP0008932_abnormal_embryonic_tissue | 1.16656174 |
68 | MP0010307_abnormal_tumor_latency | 1.16254556 |
69 | MP0003566_abnormal_cell_adhesion | 1.15216115 |
70 | MP0003448_altered_tumor_morphology | 1.13782075 |
71 | MP0000313_abnormal_cell_death | 1.12461169 |
72 | MP0008469_abnormal_protein_level | 1.04587841 |
73 | * MP0001533_abnormal_skeleton_physiology | 1.02622519 |
74 | MP0004185_abnormal_adipocyte_glucose | 1.00076416 |
75 | MP0002998_abnormal_bone_remodeling | 0.99963781 |
76 | MP0004510_myositis | 0.99058995 |
77 | MP0000343_altered_response_to | 0.96208457 |
78 | MP0009764_decreased_sensitivity_to | 0.94812595 |
79 | MP0005166_decreased_susceptibility_to | 0.94352911 |
80 | MP0009840_abnormal_foam_cell | 0.92999808 |
81 | MP0003806_abnormal_nucleotide_metabolis | 0.91796963 |
82 | MP0005075_abnormal_melanosome_morpholog | 0.91136200 |
83 | MP0003186_abnormal_redox_activity | 0.89233827 |
84 | * MP0002080_prenatal_lethality | 0.88019094 |
85 | MP0005076_abnormal_cell_differentiation | 0.87578066 |
86 | MP0000477_abnormal_intestine_morphology | 0.87444529 |
87 | MP0003705_abnormal_hypodermis_morpholog | 0.84078621 |
88 | MP0003279_aneurysm | 0.83732161 |
89 | MP0001697_abnormal_embryo_size | 0.83599049 |
90 | MP0004858_abnormal_nervous_system | 0.83066514 |
91 | MP0001542_abnormal_bone_strength | 0.83065990 |
92 | MP0003786_premature_aging | 0.82981930 |
93 | MP0005165_increased_susceptibility_to | 0.78768997 |
94 | MP0008438_abnormal_cutaneous_collagen | 0.78136722 |
95 | MP0005058_abnormal_lysosome_morphology | 0.78042520 |
96 | MP0002086_abnormal_extraembryonic_tissu | 0.76914218 |
97 | MP0001881_abnormal_mammary_gland | 0.74789732 |
98 | MP0001243_abnormal_dermal_layer | 0.74739735 |
99 | MP0003984_embryonic_growth_retardation | 0.74702448 |
100 | MP0005501_abnormal_skin_physiology | 0.73830632 |
101 | MP0005310_abnormal_salivary_gland | 0.73179683 |
102 | MP0001672_abnormal_embryogenesis/_devel | 0.72793969 |
103 | MP0005380_embryogenesis_phenotype | 0.72793969 |
104 | MP0005174_abnormal_tail_pigmentation | 0.72580600 |
105 | MP0000358_abnormal_cell_content/ | 0.72506381 |
106 | MP0002088_abnormal_embryonic_growth/wei | 0.72252993 |
107 | * MP0005390_skeleton_phenotype | 0.71593774 |
108 | MP0003795_abnormal_bone_structure | 0.71261363 |
109 | MP0001849_ear_inflammation | 0.70812607 |
110 | MP0003453_abnormal_keratinocyte_physiol | 0.66268756 |
111 | MP0005623_abnormal_meninges_morphology | 0.63983327 |
112 | MP0009763_increased_sensitivity_to | 0.63891713 |
113 | MP0001851_eye_inflammation | 0.61200430 |
114 | MP0000598_abnormal_liver_morphology | 0.61176727 |
115 | MP0003567_abnormal_fetal_cardiomyocyte | 0.60944895 |
116 | MP0003172_abnormal_lysosome_physiology | 0.60866320 |
117 | MP0001915_intracranial_hemorrhage | 0.60320142 |
118 | MP0003191_abnormal_cellular_cholesterol | 0.58051446 |
119 | MP0005621_abnormal_cell_physiology | 0.57974020 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.32462858 |
2 | IgM deficiency (HP:0002850) | 4.24790390 |
3 | Eczematoid dermatitis (HP:0000976) | 4.01377274 |
4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.70692106 |
5 | Abnormal number of erythroid precursors (HP:0012131) | 3.67972259 |
6 | Severe combined immunodeficiency (HP:0004430) | 3.58213237 |
7 | Combined immunodeficiency (HP:0005387) | 3.46963181 |
8 | Recurrent bronchitis (HP:0002837) | 3.45830724 |
9 | Recurrent abscess formation (HP:0002722) | 3.42920271 |
10 | Reticulocytopenia (HP:0001896) | 3.38070181 |
11 | T lymphocytopenia (HP:0005403) | 3.37497301 |
12 | Abnormality of T cells (HP:0002843) | 3.31821887 |
13 | Abnormality of T cell number (HP:0011839) | 3.29451458 |
14 | Recurrent fungal infections (HP:0002841) | 3.23293067 |
15 | Thrombocytosis (HP:0001894) | 3.20552753 |
16 | Petechiae (HP:0000967) | 3.19297316 |
17 | Chronic otitis media (HP:0000389) | 3.16645368 |
18 | Aplastic anemia (HP:0001915) | 3.07183509 |
19 | IgG deficiency (HP:0004315) | 2.96996820 |
20 | Abnormality of T cell physiology (HP:0011840) | 2.94851474 |
21 | Myositis (HP:0100614) | 2.94835247 |
22 | Pustule (HP:0200039) | 2.86834675 |
23 | Panhypogammaglobulinemia (HP:0003139) | 2.81548295 |
24 | Vertebral compression fractures (HP:0002953) | 2.79299671 |
25 | Recurrent viral infections (HP:0004429) | 2.76346331 |
26 | Hypertensive crisis (HP:0100735) | 2.76191462 |
27 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.73706953 |
28 | Lymphopenia (HP:0001888) | 2.69661144 |
29 | Hepatosplenomegaly (HP:0001433) | 2.68892006 |
30 | Nasal polyposis (HP:0100582) | 2.67790998 |
31 | Recurrent bacterial skin infections (HP:0005406) | 2.64375484 |
32 | Recurrent cutaneous fungal infections (HP:0011370) | 2.55732977 |
33 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.55732977 |
34 | Purpura (HP:0000979) | 2.55407212 |
35 | Abnormality of the nasal mucosa (HP:0000433) | 2.54591099 |
36 | Encephalitis (HP:0002383) | 2.52958466 |
37 | Lymphoma (HP:0002665) | 2.50921805 |
38 | Pallor (HP:0000980) | 2.50632599 |
39 | Mediastinal lymphadenopathy (HP:0100721) | 2.47673200 |
40 | Increased density of long bones (HP:0006392) | 2.45803372 |
41 | Leukocytosis (HP:0001974) | 2.44498734 |
42 | Selective tooth agenesis (HP:0001592) | 2.43790604 |
43 | Granulocytopenia (HP:0001913) | 2.42041964 |
44 | Abnormality of macrophages (HP:0004311) | 2.39022937 |
45 | Cellulitis (HP:0100658) | 2.38890823 |
46 | Trismus (HP:0000211) | 2.37680157 |
47 | Oral leukoplakia (HP:0002745) | 2.34883520 |
48 | Abnormality of glycolipid metabolism (HP:0010969) | 2.34366522 |
49 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.34366522 |
50 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.34366522 |
51 | Chest pain (HP:0100749) | 2.34137376 |
52 | Abnormality of eosinophils (HP:0001879) | 2.33720644 |
53 | Microretrognathia (HP:0000308) | 2.33227375 |
54 | Orchitis (HP:0100796) | 2.31686223 |
55 | Abnormality of B cell number (HP:0010975) | 2.30054799 |
56 | B lymphocytopenia (HP:0010976) | 2.30054799 |
57 | Chronic obstructive pulmonary disease (HP:0006510) | 2.29647497 |
58 | Obstructive lung disease (HP:0006536) | 2.29647497 |
59 | Macrocytic anemia (HP:0001972) | 2.27291938 |
60 | Recurrent skin infections (HP:0001581) | 2.26803838 |
61 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.22718202 |
62 | Meningitis (HP:0001287) | 2.18918226 |
63 | Eosinophilia (HP:0001880) | 2.18505785 |
64 | Stomatitis (HP:0010280) | 2.17688748 |
65 | Skin rash (HP:0000988) | 2.15877025 |
66 | Autoimmune thrombocytopenia (HP:0001973) | 2.15265933 |
67 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.14824107 |
68 | Ragged-red muscle fibers (HP:0003200) | 2.14249720 |
69 | Gastrointestinal infarctions (HP:0005244) | 2.12371330 |
70 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.10583426 |
71 | Poor head control (HP:0002421) | 2.09329328 |
72 | Acute hepatic failure (HP:0006554) | 2.09127653 |
73 | Birth length less than 3rd percentile (HP:0003561) | 2.09074980 |
74 | Pulmonary infiltrates (HP:0002113) | 2.08969715 |
75 | Verrucae (HP:0200043) | 2.08564003 |
76 | Papilloma (HP:0012740) | 2.08564003 |
77 | Multiple enchondromatosis (HP:0005701) | 2.08028675 |
78 | Prolonged bleeding time (HP:0003010) | 2.07569557 |
79 | Thyroiditis (HP:0100646) | 2.07018101 |
80 | Gastrointestinal stroma tumor (HP:0100723) | 2.06473355 |
81 | Basal cell carcinoma (HP:0002671) | 2.05704428 |
82 | Abnormality of the prostate (HP:0008775) | 2.05118554 |
83 | Agammaglobulinemia (HP:0004432) | 2.04461909 |
84 | Spontaneous hematomas (HP:0007420) | 2.04063751 |
85 | Muscle fiber atrophy (HP:0100295) | 2.03931928 |
86 | Gastrointestinal inflammation (HP:0004386) | 2.01873412 |
87 | Sepsis (HP:0100806) | 2.01418229 |
88 | Degeneration of anterior horn cells (HP:0002398) | 1.99763223 |
89 | Abnormality of the anterior horn cell (HP:0006802) | 1.99763223 |
90 | Increased cerebral lipofuscin (HP:0011813) | 1.98447054 |
91 | IgA deficiency (HP:0002720) | 1.97504161 |
92 | Rough bone trabeculation (HP:0100670) | 1.95010862 |
93 | Hypoplasia of the thymus (HP:0000778) | 1.94867954 |
94 | Pancytopenia (HP:0001876) | 1.94700856 |
95 | Poikiloderma (HP:0001029) | 1.93202901 |
96 | Increased IgM level (HP:0003496) | 1.92865355 |
97 | Hypergammaglobulinemia (HP:0010702) | 1.92409764 |
98 | Progressive neurologic deterioration (HP:0002344) | 1.91949804 |
99 | Vasculitis (HP:0002633) | 1.91631141 |
100 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.91513826 |
101 | Skin ulcer (HP:0200042) | 1.91463334 |
102 | Glomerulopathy (HP:0100820) | 1.90026732 |
103 | Inflammation of the large intestine (HP:0002037) | 1.89141406 |
104 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.88100266 |
105 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.88039654 |
106 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.88039654 |
107 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.85964995 |
108 | Interstitial pulmonary disease (HP:0006530) | 1.85365242 |
109 | Gastrointestinal dysmotility (HP:0002579) | 1.85008881 |
110 | Protrusio acetabuli (HP:0003179) | 1.84723819 |
111 | Bronchitis (HP:0012387) | 1.84661911 |
112 | Epistaxis (HP:0000421) | 1.84359799 |
113 | Autoimmune hemolytic anemia (HP:0001890) | 1.83817833 |
114 | Urticaria (HP:0001025) | 1.82619536 |
115 | Progressive muscle weakness (HP:0003323) | 1.82025630 |
116 | Recurrent lower respiratory tract infections (HP:0002783) | 1.81020584 |
117 | 11 pairs of ribs (HP:0000878) | 1.80504653 |
118 | Colon cancer (HP:0003003) | 1.80234284 |
119 | Distal lower limb muscle weakness (HP:0009053) | 1.80116618 |
120 | Impaired platelet aggregation (HP:0003540) | 1.79623648 |
121 | Abnormal platelet function (HP:0011869) | 1.79623648 |
122 | Colitis (HP:0002583) | 1.79188924 |
123 | Microvesicular hepatic steatosis (HP:0001414) | 1.78955477 |
124 | Optic neuritis (HP:0100653) | 1.78476545 |
125 | Retrobulbar optic neuritis (HP:0100654) | 1.78476545 |
126 | Microcytic anemia (HP:0001935) | 1.78040206 |
127 | Increased serum ferritin (HP:0003281) | 1.77836598 |
128 | Pulmonary fibrosis (HP:0002206) | 1.77622671 |
129 | Abnormality of iron homeostasis (HP:0011031) | 1.77163974 |
130 | Chronic diarrhea (HP:0002028) | 1.76508156 |
131 | Premature graying of hair (HP:0002216) | 1.76453690 |
132 | Osteomyelitis (HP:0002754) | 1.75588443 |
133 | Hypertriglyceridemia (HP:0002155) | 1.75214092 |
134 | Type 2 muscle fiber atrophy (HP:0003554) | 1.75077450 |
135 | Abnormal platelet volume (HP:0011876) | 1.74375930 |
136 | Increased IgE level (HP:0003212) | 1.73536455 |
137 | Cellular immunodeficiency (HP:0005374) | 1.73320838 |
138 | Entropion (HP:0000621) | 1.72708889 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TESK2 | 4.19755201 |
2 | MAP4K1 | 3.90000481 |
3 | VRK2 | 3.41567763 |
4 | BUB1 | 2.99196895 |
5 | NME2 | 2.85917292 |
6 | TESK1 | 2.50937629 |
7 | SMG1 | 2.42253211 |
8 | ZAP70 | 2.41060560 |
9 | BLK | 2.16907054 |
10 | TXK | 2.12529478 |
11 | WEE1 | 2.09934218 |
12 | STK10 | 2.07552400 |
13 | EIF2AK1 | 2.05301309 |
14 | RPS6KA4 | 1.90745470 |
15 | PIM2 | 1.87115340 |
16 | PRPF4B | 1.83234878 |
17 | BCKDK | 1.82101615 |
18 | LRRK2 | 1.79585485 |
19 | MAP3K10 | 1.77771440 |
20 | JAK3 | 1.77166557 |
21 | ERN1 | 1.77053454 |
22 | TRIB3 | 1.71221494 |
23 | CDC7 | 1.66265774 |
24 | RIPK4 | 1.62837693 |
25 | SCYL2 | 1.62022326 |
26 | TBK1 | 1.59640325 |
27 | EEF2K | 1.56814159 |
28 | TYK2 | 1.55559448 |
29 | NEK2 | 1.55547236 |
30 | BTK | 1.55180776 |
31 | ARAF | 1.53119660 |
32 | PKN2 | 1.49351694 |
33 | MAP3K11 | 1.43064685 |
34 | PAK4 | 1.36432438 |
35 | KIT | 1.33737625 |
36 | GRK6 | 1.32360852 |
37 | ACVR1B | 1.30526664 |
38 | LIMK1 | 1.29639577 |
39 | IKBKE | 1.28926961 |
40 | IRAK4 | 1.26257096 |
41 | RPS6KB2 | 1.23828936 |
42 | MAP2K3 | 1.20124483 |
43 | EIF2AK3 | 1.19389871 |
44 | FES | 1.19051704 |
45 | STK16 | 1.18304211 |
46 | MAP3K8 | 1.16495237 |
47 | TEC | 1.16368554 |
48 | ITK | 1.10864814 |
49 | TGFBR1 | 1.10230478 |
50 | FLT3 | 1.05687307 |
51 | LCK | 1.04945608 |
52 | MAPKAPK3 | 1.01227691 |
53 | CDK7 | 0.99853525 |
54 | TLK1 | 0.99557518 |
55 | PIM1 | 0.99287387 |
56 | SYK | 0.99020207 |
57 | CSF1R | 0.95503576 |
58 | CDK4 | 0.94169929 |
59 | DAPK1 | 0.92598108 |
60 | ILK | 0.88942849 |
61 | AURKB | 0.88717696 |
62 | CSK | 0.83572509 |
63 | IKBKB | 0.83172128 |
64 | MAP3K13 | 0.83079257 |
65 | FGFR4 | 0.81074925 |
66 | TSSK6 | 0.80728136 |
67 | PLK4 | 0.79887363 |
68 | NLK | 0.79339376 |
69 | LYN | 0.79070444 |
70 | DYRK3 | 0.78063591 |
71 | STK4 | 0.74767845 |
72 | ATR | 0.73609059 |
73 | HCK | 0.72871070 |
74 | TTN | 0.72662727 |
75 | VRK1 | 0.72455152 |
76 | EPHA2 | 0.72265100 |
77 | MST4 | 0.72177854 |
78 | IRAK3 | 0.69732132 |
79 | SRPK1 | 0.67077982 |
80 | TGFBR2 | 0.66603818 |
81 | EPHB1 | 0.65701083 |
82 | ABL2 | 0.65150794 |
83 | PLK1 | 0.64777074 |
84 | PASK | 0.63213126 |
85 | MOS | 0.62715574 |
86 | SIK1 | 0.60456470 |
87 | TNK2 | 0.60374295 |
88 | MAP3K1 | 0.59102388 |
89 | CLK1 | 0.57928008 |
90 | BRSK2 | 0.56797466 |
91 | PAK1 | 0.56086547 |
92 | CDK12 | 0.54320817 |
93 | SIK3 | 0.53146963 |
94 | JAK1 | 0.51716214 |
95 | MAP3K14 | 0.50798775 |
96 | TAOK3 | 0.50699963 |
97 | GRK7 | 0.50551226 |
98 | PRKG2 | 0.50462716 |
99 | AURKA | 0.50424776 |
100 | TAOK1 | 0.49973453 |
101 | MAPKAPK2 | 0.49679855 |
102 | MAP2K2 | 0.48526368 |
103 | CDK8 | 0.48509755 |
104 | PRKCQ | 0.47781058 |
105 | MAP3K3 | 0.46917169 |
106 | CHUK | 0.46787753 |
107 | TTK | 0.45648934 |
108 | MARK3 | 0.45101186 |
109 | MAP3K12 | 0.43841629 |
110 | BMX | 0.43093974 |
111 | ICK | 0.41820559 |
112 | NEK9 | 0.41736229 |
113 | MYLK | 0.41179409 |
114 | CDK6 | 0.39290724 |
115 | MATK | 0.39241215 |
116 | RPS6KA5 | 0.38896046 |
117 | NEK1 | 0.37585905 |
118 | FGR | 0.35106858 |
119 | DAPK3 | 0.34311906 |
120 | PTK6 | 0.34052069 |
121 | MAPK11 | 0.33591075 |
122 | HIPK2 | 0.32692032 |
123 | CDC42BPA | 0.32515927 |
124 | BRAF | 0.32142565 |
125 | CHEK1 | 0.32068286 |
126 | PRKD2 | 0.31620802 |
127 | PAK2 | 0.30917833 |
128 | TAOK2 | 0.30112140 |
129 | MKNK1 | 0.30000286 |
130 | FYN | 0.28727811 |
131 | MST1R | 0.28404183 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 3.90037013 |
2 | Ribosome_Homo sapiens_hsa03010 | 3.46391340 |
3 | Proteasome_Homo sapiens_hsa03050 | 3.21119573 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.93294804 |
5 | Mismatch repair_Homo sapiens_hsa03430 | 2.86740650 |
6 | Spliceosome_Homo sapiens_hsa03040 | 2.48224631 |
7 | Base excision repair_Homo sapiens_hsa03410 | 2.29678905 |
8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.18580650 |
9 | RNA polymerase_Homo sapiens_hsa03020 | 2.04350779 |
10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.94297656 |
11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.93353271 |
12 | Homologous recombination_Homo sapiens_hsa03440 | 1.89202106 |
13 | RNA transport_Homo sapiens_hsa03013 | 1.82922128 |
14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.82127235 |
15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.81655631 |
16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.81630809 |
17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63407765 |
18 | Cell cycle_Homo sapiens_hsa04110 | 1.63189689 |
19 | Measles_Homo sapiens_hsa05162 | 1.61653949 |
20 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.48967932 |
21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.48842477 |
22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.48218227 |
23 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.47693414 |
24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.45897955 |
25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.44197331 |
26 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.43202494 |
27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.41100243 |
28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.38722167 |
29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.37814980 |
30 | * Shigellosis_Homo sapiens_hsa05131 | 1.32484158 |
31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.31453567 |
32 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.24852908 |
33 | Legionellosis_Homo sapiens_hsa05134 | 1.23721251 |
34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22584310 |
35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18881667 |
36 | Allograft rejection_Homo sapiens_hsa05330 | 1.17954155 |
37 | RNA degradation_Homo sapiens_hsa03018 | 1.17756306 |
38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.15803272 |
39 | Apoptosis_Homo sapiens_hsa04210 | 1.11698992 |
40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.10578702 |
41 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.09879537 |
42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08924078 |
43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.05673899 |
44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.05168310 |
45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02279569 |
46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.01762765 |
47 | HTLV-I infection_Homo sapiens_hsa05166 | 1.00428449 |
48 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99027984 |
49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.98103366 |
50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93340308 |
51 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.90997660 |
52 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90398620 |
53 | Hepatitis B_Homo sapiens_hsa05161 | 0.89983596 |
54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.89925693 |
55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86950130 |
56 | Asthma_Homo sapiens_hsa05310 | 0.84102837 |
57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83316138 |
58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.81583950 |
59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80742074 |
60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79793006 |
61 | Pertussis_Homo sapiens_hsa05133 | 0.77594401 |
62 | Influenza A_Homo sapiens_hsa05164 | 0.77390113 |
63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.76369587 |
64 | Lysosome_Homo sapiens_hsa04142 | 0.75750621 |
65 | Phagosome_Homo sapiens_hsa04145 | 0.75361477 |
66 | Malaria_Homo sapiens_hsa05144 | 0.74151760 |
67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73136167 |
68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72540253 |
69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72253319 |
70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.72087630 |
71 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.71417505 |
72 | Basal transcription factors_Homo sapiens_hsa03022 | 0.70999044 |
73 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.70461604 |
74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70023904 |
75 | Thyroid cancer_Homo sapiens_hsa05216 | 0.69945368 |
76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69290984 |
77 | Purine metabolism_Homo sapiens_hsa00230 | 0.68214417 |
78 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.67482730 |
79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65717878 |
80 | Endocytosis_Homo sapiens_hsa04144 | 0.63325071 |
81 | Protein export_Homo sapiens_hsa03060 | 0.62530695 |
82 | Tuberculosis_Homo sapiens_hsa05152 | 0.61970874 |
83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60643523 |
84 | * Salmonella infection_Homo sapiens_hsa05132 | 0.60625651 |
85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60519434 |
86 | Parkinsons disease_Homo sapiens_hsa05012 | 0.59858079 |
87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59437488 |
88 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.59311836 |
89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59104143 |
90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58504508 |
91 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.55961722 |
92 | Carbon metabolism_Homo sapiens_hsa01200 | 0.55088649 |
93 | Platelet activation_Homo sapiens_hsa04611 | 0.54768386 |
94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54142280 |
95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53258454 |
96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.53144292 |
97 | Hepatitis C_Homo sapiens_hsa05160 | 0.52979928 |
98 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.52547472 |
99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51868418 |
100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51465048 |
101 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.48277320 |
102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47912351 |
103 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47129141 |
104 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45363661 |
105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45000309 |
106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44300032 |
107 | Prion diseases_Homo sapiens_hsa05020 | 0.44086901 |
108 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43641187 |
109 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.42808632 |
110 | Bladder cancer_Homo sapiens_hsa05219 | 0.42807246 |
111 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.42282508 |
112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41870804 |
113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40402069 |
114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.39735799 |
115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39579635 |
116 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.38515265 |
117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36700647 |
118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36426069 |
119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36236031 |
120 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.34977322 |
121 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34211375 |
122 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.33919173 |
123 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.33820734 |
124 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33541626 |